Effects of losartan treatment on the physicochemical properties of diabetic rat bone.

scientific article published on 2 April 2016

Effects of losartan treatment on the physicochemical properties of diabetic rat bone. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00774-016-0748-9
P698PubMed publication ID27038987

P50authorOzan AkkusQ47333811
Semir OzdemirQ57051562
Mustafa UnalQ85651737
P2093author name stringBaris Ozgur Donmez
Nurettin Oguz
Nihal Ozturk
P2860cites workPotential of RAS inhibition to improve metabolic bone disordersQ26866515
Vibrational spectroscopic imaging for the evaluation of matrix and mineral chemistryQ28393488
Bone matters: are density increases necessary to reduce fracture risk?Q33855012
Angiotensin receptors: distribution, signalling and functionQ33941829
Angiotensin II and the heart : on the intracrine renin-angiotensin system.Q33944505
Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation - role of a local renin-angiotensin systemQ34078763
Bone fragility and collagen cross-links.Q34586748
Minireview: overview of the renin-angiotensin system--an endocrine and paracrine systemQ35127232
Diabetes Mellitus: Does it Affect Bone?Q35546778
Local production of angiotensin II in the subfornical organ causes elevated drinkingQ35723465
Osteoporosis and diabetes mellitusQ35813663
FT-IR imaging of native and tissue-engineered bone and cartilageQ35844435
Assessment of fracture riskQ35992561
Infrared analysis of bone in health and diseaseQ36288337
Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studiesQ36589348
The role of the collagen matrix in skeletal fragilityQ36830308
Angiotensin II type 2 receptor blockade increases bone massQ37344123
Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitusQ37598559
The increase in renin during renin inhibition: does it result in harmful effects by the (pro)renin receptor?Q37628444
Diabetes and bone.Q37780151
Diabetes mellitus and osteoporosisQ38087556
Correlation of bone mineral density with strength and microstructural parameters of cortical bone in vitro.Q39405231
Effect of angiotensin II type 1 receptor blocker on osteoporotic rat femursQ39533055
The biomechanical integrity of bone in experimental diabetesQ43725904
Spectroscopic characterization of collagen cross-links in boneQ43755569
Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatmentQ43908109
Age-related changes in the collagen network and toughness of boneQ44058103
Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-linksQ44125426
The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitusQ44242468
Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic isletsQ44727498
Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health SurveyQ45058945
Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes.Q45859011
Angiotensin II accelerates osteoporosis by activating osteoclastsQ45875008
Foot problems as risk factors of fractures.Q46001705
Angiotensin II receptor blockage prevents diabetes-induced oxidative damage in rat heart.Q46010011
Activation of renin-angiotensin system induces osteoporosis independently of hypertensionQ46321619
Effects of angiotensin II type 1 receptor blocker on bones in mice with type 1 diabetes induced by streptozotocin.Q46506399
Older women with diabetes have an increased risk of fracture: a prospective studyQ46556380
Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly ChineseQ46780763
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control studyQ46935516
Involvement of the skeletal renin-angiotensin system in age-related osteoporosis of ageing miceQ47395118
Factors related to successful rehabilitation after hip fracture: a case-control study.Q51018094
Reduced concentrations of collagen cross-links are associated with reduced strength of bone.Q51039477
Chemical makeup of microdamaged bone differs from undamaged bone.Q51234819
Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress.Q53575266
Diabetic bone diseaseQ68032392
CT of the middiaphyseal femur: cortical bone mineral density and relation to porosityQ73023388
Type 1 and type 2 diabetes and incident hip fractures in postmenopausal womenQ74086478
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam StudyQ75363746
Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strengthQ78109893
Distribution of Collagen Cross-Links in Normal Human Trabecular BoneQ79270997
The effect of renin angiotensin system on tamoxifen resistanceQ84036521
Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibitionQ84984531
Amide I band of IR spectrum and structure of collagen and related polypeptidesQ93611121
P433issue2
P921main subjectlosartanQ410074
P304page(s)161-170
P577publication date2016-04-02
P1433published inJournal of Bone and Mineral MetabolismQ15767236
P1476titleEffects of losartan treatment on the physicochemical properties of diabetic rat bone
P478volume35

Reverse relations

Q50072393Morphometric and histologic characterization of alveolar bone from hypertensive patientscites workP2860

Search more.